ACNTNasdaqChemicals & Allied ProductsFiscal year ends December 31

ASCENT INDUSTRIES CO.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$13.53+0.04 (+0.30%)

Close on Oct 19, 2026

Market cap: $123.31M
P/E (TTM): –
Dividend yield: 0.00%

ASCENT INDUSTRIES CO. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2015-01-03	FY 2013 2013-12-28	FY 2012 2012-12-29	FY 2011 2011-12-31	FY 2010 2011-01-01	FY 2009 2010-01-02
Revenue	75	81	193	262	335	256	305	281	201	139	175	200	197	166	171	151	104
Cost of Revenue	58	70	192	219	274	233	274	–	–	–	–	–	–	–	–	–	–
Gross Profit	17	11	1.53	43	61	23	31	51	28	17	25	33	20	20	21	16	9.49
Research & Development	0.07	0	–	–	–	0.50	0.60	0.50	0.60	0.60	0.55	0.53	0.56	0.61	0.35	0.39	–
Selling, General & Admin	23	20	27	28	30	29	33	28	25	–	–	–	–	–	–	–	–
Operating Income	-7.03	-11	-37	15	27	-31	-1.71	21	2.06	-8.25	-13	16	3.50	7.32	8.81	6.19	0.70
Interest Expense	–	0.42	4.24	2.74	1.49	2.11	3.82	2.21	0.99	0.93	1.35	1.15	1.36	0.60	–	–	–
Other Non-Operating Income	0.75	0.45	0.59	0.21	-0.14	1.26	1.90	-2.57	0.31	0	0.13	0.01	0.15	0.15	0.09	0.01	-0.13
Asset Impairment Charges	1.62	0	11	0	0.23	16	0	0	0	0	17	0	0	–	–	–	–
Gain (Loss) on Investments	–	–	–	–	–	–	–	-2.57	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	0.00	-0.29	-0.25	0.02	0.85	-0.24	0.05	0.02	-0.03	-2.29	0.02	-0.03	-0.01	0.11	0.00	-0.01	0.00
Pretax Income	-5.56	-11	-41	12	25	-32	-3.76	16	1.48	-9.19	-8.47	18	4.11	5.88	8.75	6.15	0.35
Income Tax Expense	0.02	1.81	-6.92	-5.57	5.25	-4.71	-0.73	3.38	0.14	-2.20	1.80	5.39	1.21	1.89	2.95	2.12	0.13
Income from Continuing Operations	-5.58	-13	-34	18	20	-27	-3.04	13	1.34	-6.99	-10	13	2.90	3.98	5.80	4.03	0.22
Income from Discontinued Operations	6.45	-1.02	7.52	4.49	–	–	–	0	0	-0.10	-1.25	-7.16	-1.14	0.25	0	0	0.00
Net Income	0.87	-14	-27	22	20	-27	-3.04	13	1.34	-7.09	-12	5.46	1.76	4.23	5.80	4.03	0.21
EPS (Basic)(per share)	0.09	-1.35	-2.63	2.16	2.17	-2.98	-0.34	–	–	–	–	–	0.25	0.67	0.92	0.64	0.03
EPS (Diluted)(per share)	0.09	-1.35	-2.63	2.12	2.14	-2.98	-0.34	–	–	–	–	–	0.25	0.66	0.91	0.64	0.03
Shares Outstanding (Basic, Weighted)(shares)	9.64	10	10	10	9.34	9.14	8.98	8.81	8.71	8.65	8.71	8.70	6.94	6.34	6.31	6.28	–
Shares Outstanding (Diluted, Weighted)(shares)	9.64	10	10	10	9.46	9.14	8.98	8.88	8.73	8.65	8.71	8.72	6.95	6.39	6.36	6.31	–
Dividend per Share(per share)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.25	0.13	0.30	0.30	0.30	0.26	0.25	0.25	0.50	0.10
EBITDA	-5.90	-9.76	–	27	38	-20	9.36	30	9.80	-1.55	-6.40	21	8.17	10	11	8.83	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 21.1%
Operating margin: -5.9%
Net margin: -5.3%
Return on equity, FY2025: 1.0%

Financial strength

Current ratio: 4.33
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 187.9%

Valuation

P/E ratio: –
Price to sales: 1.48
Price to book: 1.55
Dividend yield: 0.00%